Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SUNIL PHARMACY | 8 | ₹4,290 |
| 2 | Schedule 2 | NUTRAKEM INDIA PRIVATE LIMITED | 1 | ₹10,000 |
| 3 | Schedule 3 | RLINK SURGICALS | 1 | ₹7,900 |
| 4 | Schedule 4 | SUNIL PHARMACY | 1 | ₹4,290 |
| 5 | Schedule 5 | RLINK SURGICALS | 1 | ₹7,560 |
Tender Value
₹46,789
EMD Value
Exempted
Closing Date
13 Jan 2026, 9:00 pmClosed
Syringe needle destroyer
Syrup Codeine phosphate 10 mg plus Chlorpheneramine
Common cold tab
Hydrocortisone sodium succinate inj
Cipzox tab
Paracetamol tab
8788770
GEM/2026/B/7066255
Two Packet Bid
Syringe needle destroyer
Ladakh; Leh Ladakh
Item wise evaluation
PRODUCT
6 documents required · 6 mandatory
2 yrs
₹31
₹2 L
30%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Syringe needle destroyer | LEH | 2 | 30 days |
| Syrup Codeine phosphate 10 mg plus Chlorpheneramine | LEH | 100 | 30 days |
| Common cold tab | Hydrocortisone Sodium Succinate LEH Inj | 10,000 | 30 days |
| Hydrocortisone sodium succinate inj | LEH | 300 | 30 days |
| Cipzox tab | LEH | 6,000 | 30 days |
| Paracetamol tab | LEH | 100 | 30 days |
Exempted
14 Jan 2026
3 Jan 2026
13 Jan 2026
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8788770.pdf
GEM_BID
scanned_20260103-1108_2026-01-03-11-17-06_578e89b0166e5f59dad833abd1d2143a.pdf
BOQ
boq_item_sample_file-7_2026-01-03-11-17-06_c7224b9449c5abca5d4999e9600a0313.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
GEM_OTHER • 0.52 MB
gtc.pdf
GEM_OTHER • 0.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .